CTI Life Sciences Fund makes venture capital investments in high-quality emerging life science companies at the pre-clinical and clinical development stages. Our main guiding principle is to catalyze, transform and invest in the future of life sciences across Canada, the U.S., and Europe.
CTI Life Sciences Fund strategy revolves around the "Inception-2-Inflection" concept. We will invest from birthing new companies to more advanced-clinical-stage organizations. The Fund is driven by a complementary management team providing a deep scientific knowledge base, board management and governance experience, and business acumen. We seek highly differentiated and scalable ideas, that we will chaperone forward to growth.
Company Details
- Employees
- 10
- Founded
- 2006
- Address
- 1 Place Ville-Marie, Suite 1050,canada
- Industry
- Venture Capital And Private Equity Principals
- NAICS
-
Miscellaneous Intermediation
- Website
- https://www.ctisciences.com/
- Keywords
- Princeton.
- HQ
- Montreal, Quebec
Cti Life Sciences Fund Questions
Cti Life Sciences Fund's website is https://www.ctisciences.com/
Cti Life Sciences Fund's LinkedIn profile is https://ca.linkedin.com/company/cti-lsf
Cti Life Sciences Fund has
10 employees.
View email and phone details for 10
employees at Cti Life Sciences Fund.
Cti Life Sciences Fund's industry is
Venture Capital and Private Equity Principals
Cti Life Sciences Fund's top competitors are
Admare Bioinnovations,
Glycomine Inc.,
Epitopea,
Foster Rosenblatt,
Find Therapeutics,
Genesys Capital,
Amplitude Ventures,
Amolyt Pharma,
Novateur Ventures Inc.,
Lumira Ventures.
Cti Life Sciences Fund's categories are Venture Capital and Private Equity Principals
Cti Life Sciences Fund's founding year is 2006
